Company Analysis

Connect Biopharma Holdings Limited (CNTB)

Nasdaq: CNTB · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2020
Grade5.1
◀ Past 5.4● Present 5.2▶ Future 4.8
3 est.

Who owns Connect Biopharma Holdings Limited

As filed with the SEC
Holders of 5% or more
4
Panacea Innovation Limited holds 21.2% of Ordinary Shares, as its SCHEDULE 13D/A filed Apr 1, 2026 says.
Directors and officers
8
report now, of 8 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Panacea Innovation Limited
SCHEDULE 13D/A · filed Apr 1, 2026 · Ordinary Shares · 21.5% in Nov 26, 2025
21.2%
Wubin Pan
SCHEDULE 13G · filed Apr 14, 2026 · Ordinary Shares, par value $0.000174 per share · 10.8% in Feb 17, 2026
9.6%
Ikarian Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Ordinary Shares, par value $0.000174 per Share · 8.8% in Feb 17, 2026
6.9%
Braden M Leonard
SCHEDULE 13G · filed Oct 6, 2026 · Ordinary Shares, par value $0.000174 per Share
6.77%
Wei Zheng
SCHEDULE 13G/A · filed Aug 14, 2026 · Ordinary shares, par value $0.000174 · reported falling below 5%, from 6.2% in May 15, 2026
under 5%
What CNTB reports owning in othersstakes of 5% or more, and other ties

6 subsidiaries in 4 countries, from the list filed with the 10-K filed Mar 31, 2026.

Insider tradesForm 4
0sales
2purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$4.4Mbought, in dollars
Open-market trades on Form 4 from Oct 1, 2025 to Oct 1, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
26
2026 runs to Oct 1, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 8 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Huang Jamesdirector0$002$4.4M
SI Assistanton CNTB · research, not advice